About
Mikael S. Lindström, PhD degree in Experimental Oncology 2004 and Docent in Experimental Pathology obtained 2012 at Karolinska Institutet i Stockholm, Sweden.
Line of research
My team is specifically interested in molecular mechanisms underlying the regulation of ribosome biogenesis, how the cell senses errors in the complex process of ribosome biogenesis and how these processes in turn can be used in the development of novel anti-cancer therapies. To investigate ribosome biogenesis and nucleolar structure, the team uses various microscopy technologies, ribosome profiling, rDNA assays, transcriptomics, translatomics, and proteomics. We also work a lot with small molecules and functional screens. Main lines and interests of research: 1. Characterization of ribosome biogenesis regulatory proteins and potential role in cancer development, biomarker discovery for personalized cancer medicine. 2. Regulation of ribosome biogenesis and protein synthesis in normal CNS cells and in glioma, including heterogeneity of ribosome in relation to glioma cellular diversity. 3. Targeting of ribosome biogenesis or mature ribosome function in cancer. 4. Functional studies of ribosomal proteins. 5. We also currently extensively collaborate in a joint project with Prof Sinisa Volarevic at Univ Rijeka on RPL24 mouse model. Talk given "Targeting Ribosome Biogenesis in Cancer: Current Insights” that was held on november 14, 2024.
Top-100
Fields of science
|
2
4
6
8
10
12
14
16
18
20
|
|
|
Cancer Research
|
Cancer Research, 19, 35.85%
Cancer Research
19 publications, 35.85%
|
|
Oncology
|
Oncology, 18, 33.96%
Oncology
18 publications, 33.96%
|
|
Molecular Biology
|
Molecular Biology, 15, 28.3%
Molecular Biology
15 publications, 28.3%
|
|
Cell Biology
|
Cell Biology, 15, 28.3%
Cell Biology
15 publications, 28.3%
|
|
Biochemistry
|
Biochemistry, 8, 15.09%
Biochemistry
8 publications, 15.09%
|
|
Genetics
|
Genetics, 5, 9.43%
Genetics
5 publications, 9.43%
|
|
Multidisciplinary
|
Multidisciplinary, 5, 9.43%
Multidisciplinary
5 publications, 9.43%
|
|
General Medicine
|
General Medicine, 4, 7.55%
General Medicine
4 publications, 7.55%
|
|
Biophysics
|
Biophysics, 4, 7.55%
Biophysics
4 publications, 7.55%
|
|
Developmental Biology
|
Developmental Biology, 3, 5.66%
Developmental Biology
3 publications, 5.66%
|
|
Hematology
|
Hematology, 2, 3.77%
Hematology
2 publications, 3.77%
|
|
Pharmacology
|
Pharmacology, 1, 1.89%
Pharmacology
1 publication, 1.89%
|
|
Molecular Medicine
|
Molecular Medicine, 1, 1.89%
Molecular Medicine
1 publication, 1.89%
|
|
Electrical and Electronic Engineering
|
Electrical and Electronic Engineering, 1, 1.89%
Electrical and Electronic Engineering
1 publication, 1.89%
|
|
Pathology and Forensic Medicine
|
Pathology and Forensic Medicine, 1, 1.89%
Pathology and Forensic Medicine
1 publication, 1.89%
|
|
Neurology
|
Neurology, 1, 1.89%
Neurology
1 publication, 1.89%
|
|
Cellular and Molecular Neuroscience
|
Cellular and Molecular Neuroscience, 1, 1.89%
Cellular and Molecular Neuroscience
1 publication, 1.89%
|
|
Building and Construction
|
Building and Construction, 1, 1.89%
Building and Construction
1 publication, 1.89%
|
|
Neurology (clinical)
|
Neurology (clinical), 1, 1.89%
Neurology (clinical)
1 publication, 1.89%
|
|
2
4
6
8
10
12
14
16
18
20
|
Journals
Citing journals
Publishers
|
2
4
6
8
10
12
14
|
|
|
Springer Nature
14 publications, 26.42%
|
|
|
American Association for Cancer Research (AACR)
6 publications, 11.32%
|
|
|
Elsevier
5 publications, 9.43%
|
|
|
Taylor & Francis
4 publications, 7.55%
|
|
|
Oxford University Press
4 publications, 7.55%
|
|
|
MDPI
3 publications, 5.66%
|
|
|
Public Library of Science (PLoS)
3 publications, 5.66%
|
|
|
American Society for Biochemistry and Molecular Biology
3 publications, 5.66%
|
|
|
Hindawi Limited
2 publications, 3.77%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.89%
|
|
|
American Society for Microbiology
1 publication, 1.89%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 1.89%
|
|
|
Impact Journals
1 publication, 1.89%
|
|
|
Spandidos Publications
1 publication, 1.89%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 1.89%
|
|
|
AccScience Publishing
1 publication, 1.89%
|
|
|
2
4
6
8
10
12
14
|
Organizations from articles
Countries from articles
|
5
10
15
20
25
30
35
40
45
|
|
|
Sweden
|
Sweden, 42, 79.25%
Sweden
42 publications, 79.25%
|
|
Denmark
|
Denmark, 12, 22.64%
Denmark
12 publications, 22.64%
|
|
USA
|
USA, 10, 18.87%
USA
10 publications, 18.87%
|
|
Country not defined
|
Country not defined, 7, 13.21%
Country not defined
7 publications, 13.21%
|
|
China
|
China, 4, 7.55%
China
4 publications, 7.55%
|
|
United Kingdom
|
United Kingdom, 3, 5.66%
United Kingdom
3 publications, 5.66%
|
|
Germany
|
Germany, 2, 3.77%
Germany
2 publications, 3.77%
|
|
Australia
|
Australia, 1, 1.89%
Australia
1 publication, 1.89%
|
|
Spain
|
Spain, 1, 1.89%
Spain
1 publication, 1.89%
|
|
Netherlands
|
Netherlands, 1, 1.89%
Netherlands
1 publication, 1.89%
|
|
Norway
|
Norway, 1, 1.89%
Norway
1 publication, 1.89%
|
|
Turkey
|
Turkey, 1, 1.89%
Turkey
1 publication, 1.89%
|
|
Finland
|
Finland, 1, 1.89%
Finland
1 publication, 1.89%
|
|
Croatia
|
Croatia, 1, 1.89%
Croatia
1 publication, 1.89%
|
|
Czech Republic
|
Czech Republic, 1, 1.89%
Czech Republic
1 publication, 1.89%
|
|
5
10
15
20
25
30
35
40
45
|
Citing organizations
Citing countries
- We do not take into account publications without a DOI.
- Statistics recalculated daily.
